Met Life Investment Management, LLC Anika Therapeutics, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 8,516 shares of ANIK stock, worth $148,093. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,516
Previous 8,516
-0.0%
Holding current value
$148,093
Previous $210,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
37 transactions
Others Institutions Holding ANIK
# of Institutions
111Shares Held
11.1MCall Options Held
1.8KPut Options Held
1.9K-
Trigran Investments, Inc.2.02MShares$35.2 Million4.19% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$27.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA765KShares$13.3 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY700KShares$12.2 Million3.96% of portfolio
-
Dimensional Fund Advisors LP Austin, TX657KShares$11.4 Million0.0% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $254M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...